NSE · ERIS
Eris Lifesciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#406
of 5,096 stocks
▼ 171W
Peak #389 · 21 Sep 2026
Operating in Healthcare, Eris Lifesciences Limited is well-owned by domestic institutions (21% DII), is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
17,135.12 Cr
P/E Ratio
27.27
P/B Ratio
4.40
ROE
16.62%
ROCE
16.04%
Dividend Yield
0.58%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 873.25 Cr | 756.56 Cr | 807.45 Cr | 792.41 Cr |
| Net Profit | 143.32 Cr | 279.10 Cr | 108.83 Cr | 134.47 Cr |
| EPS | 10.28 | 20.60 | 7.32 | 8.82 |
| Operating Profit | 226.54 Cr | 206.23 Cr | 211.29 Cr | 221.94 Cr |
Shareholding pattern
Promoter
54.14%
Public
45.86%
PUBLIC BREAKDOWN
FII
5.75%
DII
20.72%
MF (within DII)
18.88%
Individuals
10.26%
Mutual fund holdings
₹3,144.89
Cr total
83
Schemes
21
Fund Houses
₹3,144.89 Cr
Total Exposure
HDFC Mutual Fund₹1,484.55 Cr (47.2%)
Franklin Templeton Mutual Fund₹679.01 Cr (21.6%)
UTI Mutual Fund₹190.93 Cr (6.1%)
DSP Mutual Fund₹188.94 Cr (6.0%)
HSBC Mutual Fund₹184.93 Cr (5.9%)
Others₹416.53 Cr (13.2%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 29 May 2026 | Dividend | Interim Dividend - Rs 7.21 Per Share |
| 13 Feb 2025 | Dividend | Interim Dividend - Rs 7.35 Per Share |
| 17 Sep 2024 | Other | Annual General Meeting |
| 15 Sep 2023 | Other | Annual General Meeting |
| 23 Aug 2022 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.